Updated: Jan 10, 2025
The average Travere Therapeutic stock price target is 26.82 with a max estimate of 42.00 and a min estimate of 18.00
Review Travere Therapeutic earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Jan 10, 2025
No Data